Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria (Plasmodium Falciparum)”

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05676645
What this trial is testing

Pharmacokinetics of Antimalarials in Breastfeeding Ugandan Mother-infant Pairs

Who this might be right for
Malaria,Falciparum
University of Liverpool 30
Post-approval studies (Phase 4)UnknownNCT03726593
What this trial is testing

Drug Combinations of Atovaquone-Proguanil (AP) With ACT

Who this might be right for
Plasmodium Falciparum Malaria (Drug Resistant)
Armed Forces Research Institute of Medical Sciences, Thailand 252
Large-scale testing (Phase 3)Study completedNCT06173206
What this trial is testing

Parasite Clearance and Protection From Infection (PCPI) in Cameroon

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 902
Testing effectiveness (Phase 2)Study completedNCT03896724
What this trial is testing

Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso

Who this might be right for
Malaria,Falciparum
University of Oxford 450
Large-scale testing (Phase 3)Study completedNCT04319380
What this trial is testing

Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study

Who this might be right for
Malaria,FalciparumChild, Only
London School of Hygiene and Tropical Medicine 5,098
Large-scale testing (Phase 3)Study completedNCT02987270
What this trial is testing

Evaluation of Community-based Mass Screening and Treatment for Malaria in Western Kenya

Who this might be right for
Malaria,Falciparum
Simon Kariuki 90,000
Post-approval studies (Phase 4)Study completedNCT06083688
What this trial is testing

Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi

Who this might be right for
Malaria,FalciparumAnemia in Children
Liverpool School of Tropical Medicine 788
Not applicableUnknownNCT05025761
What this trial is testing

Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar

Who this might be right for
Plasmodium Falciparum Infection
Macfarlane Burnet Institute for Medical Research and Public Health Ltd 1,200
Early research (Phase 1)UnknownNCT02739763
What this trial is testing

Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)

Who this might be right for
Malaria
University of Oxford 200
Not applicableStudy completedNCT04093765
What this trial is testing

Mass Screening and Treatment for Reduction of Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 5,542
Not applicableStudy completedNCT02001428
What this trial is testing

Malaria in Early Life Study

Who this might be right for
Plasmodium Falciparum MalariaPlasmodium Vivax Malaria
Gadjah Mada University 757
Post-approval studies (Phase 4)Study completedNCT02168569
What this trial is testing

In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children

Who this might be right for
Malaria
Centro de Investigacao em Saude de Manhica 700
Post-approval studies (Phase 4)Study completedNCT02084602
What this trial is testing

Assessment of Artesunate/Mefloquine in the Peruvian Amazon

Who this might be right for
Malaria, Falciparum
Instituto Nacional de Salud. Peru 45
Not applicableStudy completedNCT01872702
What this trial is testing

Targeted Chemo-elimination (TCE) of Malaria

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 8,000
Testing effectiveness (Phase 2)Study completedNCT04577066
What this trial is testing

Safety and Preliminary Protective Efficacy of Genetically Attenuated GA2 Parasites.

Who this might be right for
Plasmodium Falciparum Malaria
Leiden University Medical Center 43
Not applicableStudy completedNCT03387631
What this trial is testing

Efficacy And Safety Of AL For The Treatment Of Uncomplicated Falciparum Malaria In Mainland Tanzania

Who this might be right for
Uncomplicated Malaria
National Institute for Medical Research, Tanzania 344
Testing effectiveness (Phase 2)WithdrawnNCT01783340
What this trial is testing

Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis

Who this might be right for
Malaria, Falciparum
Radboud University Medical Center
Early research (Phase 1)Study completedNCT02223871
What this trial is testing

Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 8
Early research (Phase 1)Study completedNCT01728701
What this trial is testing

Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis

Who this might be right for
MalariaPlasmodium Falciparum
Sanaria Inc. 30
Early research (Phase 1)Study completedNCT02996695
What this trial is testing

Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian Adults

Who this might be right for
Plasmodium Falciparum Infection
National Institute of Allergy and Infectious Diseases (NIAID) 62
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation